Jitendra Mohan Sells 157,500 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CEO Jitendra Mohan sold 157,500 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $131.58, for a total transaction of $20,723,850.00. Following the transaction, the chief executive officer directly owned 4,531,732 shares of the company’s stock, valued at $596,285,296.56. This represents a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jitendra Mohan also recently made the following trade(s):

  • On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51.

Astera Labs Trading Down 0.2%

Shares of ALAB traded down $0.26 during mid-day trading on Thursday, hitting $126.08. The company’s stock had a trading volume of 4,151,528 shares, compared to its average volume of 4,535,431. The firm has a 50-day simple moving average of $145.64 and a 200 day simple moving average of $166.93. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm has a market capitalization of $21.46 billion, a P/E ratio of 116.98, a P/E/G ratio of 2.49 and a beta of 1.74.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue was up 91.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analysts Set New Price Targets

ALAB has been the topic of several recent analyst reports. Citigroup lowered their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Northland Securities upped their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. BNP Paribas Exane began coverage on Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating for the company. Finally, Royal Bank Of Canada initiated coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $202.22.

Read Our Latest Analysis on ALAB

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ALAB. Vanguard Group Inc. grew its holdings in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the last quarter. State Street Corp lifted its position in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares in the last quarter. Fred Alger Management LLC boosted its stake in shares of Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after acquiring an additional 393,250 shares during the last quarter. Finally, Morgan Stanley increased its position in Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after purchasing an additional 480,009 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.